BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2595078)

  • 1. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological changes in prolactinoma induced by bromocriptine treatment].
    Scanarini M
    Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of prolactin-secreting pituitary adenomas.
    Neal JH; Weiss MH
    West J Med; 1990 Nov; 153(5):546-7. PubMed ID: 2260295
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of macroprolactinomas at Auckland Hospital 1975-91.
    Wallace EA; Holdaway IM
    N Z Med J; 1995 Feb; 108(994):50-2. PubMed ID: 7885646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactinoma.
    Serri O; Beauregard H; Somma M
    Curr Ther Endocrinol Metab; 1994; 5():41-3. PubMed ID: 7704764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolactin adenomas in women under 20 years of age: apropos of 11 cases].
    Cáceres Narizzano O; Molocznik I; Artese R; Kulczycki A; Boero L; Caputi E
    Medicina (B Aires); 1988; 48(5):459-68. PubMed ID: 3255036
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
    Kobras G
    Pathologe; 1992 Jul; 13(4):183-9. PubMed ID: 1508856
    [No Abstract]   [Full Text] [Related]  

  • 10. Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.
    Hamester U; Saeger W; Lüdecke DK
    Histol Histopathol; 1987 Apr; 2(2):135-42. PubMed ID: 2980713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine treatment of postoperative prolactinoma patients.
    Yang DY; Wang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):346-50. PubMed ID: 8087709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of prolactinoma].
    Serri O; Somma M; Beauregard H; Rasio E; Comtois R; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):496-9. PubMed ID: 7905686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for medical as opposed to surgical treatment of prolactinomas.
    Besser M
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():27-30. PubMed ID: 8103956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medically treated prolactin-secreting pituitary adenomas: when should we operate?
    Vale FL; Deukmedjian AR; Hann S; Shah V; Morrison AD
    Br J Neurosurg; 2013 Feb; 27(1):56-62. PubMed ID: 22938595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of combined surgical and medical therapy in patients with prolactin-secreting pituitary macroadenomas.
    Candrina R; Galli G; Bollati A; Pizzocolo G; Orlandini A; Gualandi GF; Giustina G
    Neurosurgery; 1987 Dec; 21(6):894-7. PubMed ID: 3437957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.